United States 118th Congress ✓ Enacted · P.L. 118-23 1 R cosponsors

HR 1734 — TRANQ Research Act of 2023

Last action — Became Public Law No: 118-23.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced March 23, 2023. Enacted.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 52% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.

Bill Text

What changed in the latest version

61 added · 61 removed

Plain-language change summary

The amendment to HR 1734 updates the text to incorporate provisions related to xylazine detection and analysis, specifying definitions for "Federal laboratory" and "institution of higher education" based on existing laws. This clarification helps establish a clear framework for the National Institute of Standards and Technology's research activities concerning illicit drugs and other substances. By defining these terms, the amendment ensures that relevant entities are precisely identified for the coordination of science and research efforts.

→
Previous
Latest
[Congressional Bills 118th Congress] [From the U.S.
[118th Congress Public Law 23] [From the U.S.
Government Publishing Office] [H.R.
Government Publishing Office] [[Page 137 STAT.
1734 Engrossed Amendment Senate (EAS)] <DOC> In the Senate of the United States, June 22, 2023.
125]] Public Law 118-23 118th Congress An Act To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.
Resolved, That the bill from the House of Representatives (H.R.
<<NOTE:
1734) entitled ``An Act to require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.'', do pass with the following AMENDMENT:
Dec.
Strike all after the enacting clause and insert the following:
19, 2023 - [H.R.
SECTION 1.
1734]>> Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, <<NOTE:
SHORT TITLE.
Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023.>> SECTION 1.
<<NOTE:
15 USC 271 note.>> SHORT TITLE.
XYLAZINE DETECTION AND ANALYSIS.
<<NOTE:
15 USC 278u.>> XYLAZINE DETECTION AND ANALYSIS.
(2) Federal laboratory.--The term ``Federal laboratory'' has the meaning given such term in section 4 of the Stevenson- Wydler Technology Innovation Act of 1980 (15 U.S.C.
(2) Federal laboratory.--The term ``Federal laboratory'' has the meaning given such term in section 4 of the Stevenson-Wydler Technology Innovation Act of 1980 (15 U.S.C.
(4) Institution of higher education.--The term ``institution of higher education'' has the meaning given such term in section 101 of the Higher Education Act of 1965 (19 U.S.C.
(4) Institution of higher education.--The term ``institution of higher education'' has the meaning given such term in section of the Higher Education Act of 1965 (19 U.S.C.
(C) new data tools, techniques, and processes to identify and publicly disclose relevant information concerning substances containing xylazine, novel synthetic opioids, or other new psychoactive substances;
(C) new data tools, techniques, and processes to identify and publicly disclose relevant information concerning [[Page 137 STAT.
126]] substances containing xylazine, novel synthetic opioids, or other new psychoactive substances;
(3) convene and consult with organizations engaged in the analysis of new psychoactive substances to develop coordinated strategies and voluntary best practices for the safe handling, transport, data-sharing, and analysis of substances containing xylazine, novel synthetic opioids, or other new psychoactive substances, including-- (A) the Drug Enforcement Administration;
(3) <<NOTE:
Consultation.
Strategies.>> convene and consult with organizations engaged in the analysis of new psychoactive substances to develop coordinated strategies and voluntary best practices for the safe handling, transport, data-sharing, and analysis of substances containing xylazine, novel synthetic opioids, or other new psychoactive substances, including-- (A) the Drug Enforcement Administration;
(a) Study.-- (1) In general.--The Comptroller General of the United States shall conduct a study of the capabilities of the Federal Government to respond to the threats of new psychoactive substances such as xylazine.
(a) Study.-- (1) In general.--The Comptroller General of the United States shall conduct a study of the capabilities of the Federal [[Page 137 STAT.
127]] Government to respond to the threats of new psychoactive substances such as xylazine.
Attest:
Approved December 19, 2023.
Secretary.
LEGISLATIVE HISTORY--H.R.
118th CONGRESS 1st Session H.R.
1734 (S.
1734 _______________________________________________________________________ AMENDMENT
1280):
--------------------------------------------------------------------------- HOUSE REPORTS:
No.
118-50 (Comm.
on Science, Space, and Technology).
CONGRESSIONAL RECORD, Vol.
169 (2023):
May 9, 11, considered and passed House.
June 22, considered and passed Senate, amended.
Dec.
4, House concurred in Senate amendment.
<all>
⬇ Download PDF
View plain text versions (7)

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the House Committee on Science, Space, and Technology.

  4. Committee Consideration and Mark-up Session Held.

  5. Ordered to be Reported (Amended) by the Yeas and Nays: 36 - 0.

  6. Reported (Amended) by the Committee on Science, Space, and Technology. H. Rept. 118-50.

  7. Reported (Amended) by the Committee on Science, Space, and Technology. H. Rept. 118-50.

  8. Placed on the Union Calendar, Calendar No. 34.

  9. Mr. Miller (OH) moved to suspend the rules and pass the bill, as amended.

  10. Considered under suspension of the rules. (consideration: CR H2149-2151)

  11. DEBATE - The House proceeded with forty minutes of debate on H.R. 1734.

  12. At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  13. Considered as unfinished business. (consideration: CR H2295-2296)

  14. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212). (text: 5/9/2023 CR H2149)

  15. On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212). (text: 5/9/2023 CR H2149)

  16. Motion to reconsider laid on the table Agreed to without objection.

  17. Received in the Senate, read twice.

  18. Measure laid before Senate by unanimous consent. (consideration: CR S2250)

  19. Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S2250-2251)

  20. Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S2250-2251)

  21. Message on Senate action sent to the House.

  22. Mr. Lucas moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H6087-6089)

  23. DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and agree to the Senate amendment to H.R. 1734.

  24. Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H6087-6088)

  25. On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H6087-6088)

  26. Motion to reconsider laid on the table Agreed to without objection.

  27. Presented to President.

  28. Presented to President.

  29. Signed by President.

  30. Signed by President.

  31. Became Public Law No: 118-23.

  32. Became Public Law No: 118-23.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare technology
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 1734 do?
To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.
Who sponsors HR 1734?
HR 1734 is sponsored by Collins, Mike (Republican).
What is the current status of HR 1734?
This bill has been enacted into law. Introduced March 23, 2023. Enacted.
Where can I track HR 1734?
Track HR 1734 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 1734

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 1734

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →